Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Wellbeing Digital Sciences Inc (OP: KONEF )

0.0210 UNCHANGED
Streaming Delayed Price Updated: 2:22 PM EDT, Jun 30, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0210
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0210
Today's Range 0.0210 - 0.0210
52wk Range 0.0180 - 2.600
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Wellbeing Digital Net Loss Continues To Grow: Q2 Reaches $5.15M, Up By 552% YoY
Wellbeing Digital Sciences Inc. (OTCQB:KONEF 
Via Benzinga
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today
GAINERS: Mind Medicine (NASDAQ: 
Via Benzinga

Performance

YTD
-92.76%
-92.76%
1 Month
-46.84%
-46.84%
3 Month
-90.45%
-90.45%
6 Month
-92.76%
-92.76%
1 Year
-98.37%
-98.37%

More News

Read More
Wellbeing Digital, Small Pharma Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From March 7, 2022
Via Benzinga
Ketamine One Shares Uplisted To OTCQB
Via Benzinga
Psychedelic Stock Gainers And Losers From March 4, 2022
Via Benzinga
Psychedelic Stock Gainers And Losers From March 1, 2022
Via Benzinga
Psychedelic Stock Gainers And Losers From February 28, 2022
Via Benzinga
Psychedelic Stock Gainers And Losers From February 14, 2022
Via Benzinga
Wellbeing Digital Sciences' Integrated Approach Aims To Capture Emerging Mental Health Tech And Psychedelics Market
Via Benzinga
Wellbeing Digital Sciences' Subsidiary KGK Science Forms Tactical Partnership With Nova Mentis
Via Benzinga
Psyched: Delix Raises $30M, New Ketamine Study For Alcohol Use Disorder, FDA Approves Ketamine Trial For ALS
Via Benzinga
Cannabis Movers & Shakers: HEXO, Agrify, MindMed, KetamineOne
Via Benzinga
Cannabis Dispensary Roundup: Verano, Jushi, Cresco, KetamineOne
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Dispensary Roundup: Ascend Wellness, Ketamine One, Cresco, Kiaro, TILT, BELLEBUD
Via Benzinga
Topics Cannabis
Exposures Cannabis
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
Via Benzinga
Psyched: Delic Buys 10 Ketamine Clinics For $10M, Atai Launches Ibogaine Human Trials, Small Pharma Concludes Phase 1 DMT Study
Via Benzinga
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
Via Benzinga
Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold
Via Benzinga
KetamineOne Capital Forms Medical Advisory Board, Will Oversee Development Of Its Mental-Health Platform
Via Benzinga
Expanding Mental Health Provider; 15 Clinics in North America & Cutting-Edge Clinical Research Programs: KetamineOne (OTC: KONEF)
Via Get News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.